Peer review reports
From: Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
Original Submission | ||
---|---|---|
12 Jan 2022 | Submitted | Original manuscript |
20 Jan 2022 | Author responded | Author comments - Chenxing Wang |
Resubmission - Version 2 | ||
20 Jan 2022 | Submitted | Manuscript version 2 |
1 Feb 2022 | Author responded | Author comments - Chenxing Wang |
Resubmission - Version 3 | ||
1 Feb 2022 | Submitted | Manuscript version 3 |
22 Apr 2022 | Reviewed | Reviewer Report |
1 Jun 2022 | Reviewed | Reviewer Report |
13 Jun 2022 | Author responded | Author comments - Chenxing Wang |
Resubmission - Version 4 | ||
13 Jun 2022 | Submitted | Manuscript version 4 |
15 Jun 2022 | Reviewed | Reviewer Report |
24 Jun 2022 | Reviewed | Reviewer Report |
5 Jul 2022 | Author responded | Author comments - Chenxing Wang |
Resubmission - Version 5 | ||
5 Jul 2022 | Submitted | Manuscript version 5 |
Publishing | ||
13 Jul 2022 | Editorially accepted | |
26 Jul 2022 | Article published | 10.1186/s12885-022-09901-w |